3 ms·
Xofluza’s phase III was almost 1,900 patients. Generally the size of the trial scales with the potential population and the statistical power you are shooting
by refurb 8y ago
Xofluza’s phase III was almost 1,900 patients.
Generally the size of the trial scales with the potential population and the statistical power you are shooting for.
- Retric 8y agoJust to add, it’s also a question of how many studies you can preform and not publish the results. Doing 100 different 30 person studies is vastly easier than doing the same with 2,000 people studies.